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ABSTRACT
Objective: This study was aimed to evaluate the bioactive potential (antimicrobial and antioxidant) of marine actinobacteria isolated from Thottada 
marine sediment, Kannur, Kerala.
Methods: The study involved isolation of marine actinobacteria from Thottada marine sediments, followed by antimicrobial and antioxidant activity 
of the crude extract. Finally, identification of potential isolates.
Results: In this study, a total of 6 actinobacterial colonies were isolated, out of which only one isolate DV-35 showed maximum anti-microbial and 
anti-oxidant activity. The isolate DV-35 showed maximum inhibitory activity against Gram-negative bacterial pathogens Pseudomonas aeruginosa 
(18 mm) followed by Salmonella typhi (17 mm) and Klebsiella sp. (13 mm) at a dose of 100 µg/ml. In antifungal activity, extract showed maximum 
activity against Aspergillus niger (19 mm) followed Aspergillus flavus (17 mm) at a dose of 100 µg/ml. Simultaneously the extract was evaluated for its 
antioxidant activity. The potential isolate DV-35 also showed moderately higher antioxidant activity in various screening assay, viz., 2,2-diphenyl-1-
picrylhydrazyl scavenging assay (80.12%), metal chelating assay and reducing power assay (76%) at a concentration of 100 µg/ml. Potential isolate 
DV-35 was identified as Streptomyces variabilis DV-35 using molecular 16S rRNA sequencing.
Conclusion: The results obtained suggest that the extract is having bioactive metabolites that can be considered as a potential source for anti-
microbial and anti-oxidant drug development.
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INTRODUCTION
In recent years, many novel bioactive metabolites are produced from 
natural products [1]. Pathogens are becoming highly resistance to 
available drugs and have become more problematic to human health. 
To overcome the worldwide resistance to these pathogenic bacteria, 
the discovery of new and novel antimicrobial drug is a thirst area of 
research [2]. A major role that caused drug resistance in pathogenic 
microbes is the improper usage of antibiotics. By altering their genetic 
structure and metabolism pathogenic microbes gain resistance toward 
common available antibiotics [3,4]. On the other hand, there is a pressing 
need for the development of bio-antioxidant drugs in the current 
world. Similarly, antioxidant compounds have an ability to inhibit the 
free radicals; these free radicals play a major role in the oxidization 
of nucleic acids, proteins, lipids which trigger the degenerative 
disease. Highly reactive oxygen species and free radicals are present 
in the biological system. Antioxidants can prevent disease like cancer, 
coronary heart disease and also have a wide range of applications as 
dietary supplements [5-7]. Along with these antioxidants have various 
industrial uses, such as with gasoline, to stop the degradation of rubber 
and in cosmetics and also as food preservatives [8]. Hence, there is an 
urgent need for the development of new antimicrobial and antioxidant 
drugs.
The members of the group actinobacteria are widely distributed 
in marine and terrestrial ecosystems. They are non-motile, aerobic 
and Gram-positive bacteria with high G+C (70-80%) content in 
their DNA. Marine actinomycetes posses’ high commercial and 
pharmacological interest and they are well-known producers of many 
secondary metabolites [9]. Marine actinobacteria are an important 
source of marine environment possessing many important and 
interesting features. Many clinical and pharmaceutical important 
natural products are produced from marine actinobacteria [10]. 
Streptomyces, Micromonospora, and Nocardia are the three most 
common genera in the marine environment which acted as a potential 
source for new novel antibiotics. More than 70% of antibiotics or 
bioactive compounds that are available now are contribution of 
marine actinobacteria [11]. Among the commercially available and 
widely used antibiotics (erythromycin, chloramphenicol, tetracycline 
and gentamicin), most of them are isolated from Streptomyces sp. For 
the discovery of new antibiotics marine actinobacteria still hold the 
key position. Search of new antimicrobial and antioxidant drugs from 
actinomycetes has risen due to the prevalence of antibiotic resistance 
pathogen and pharmacological limitations, respectively. To cope up 
with this researchers have started looking for novel micro-organisms 
in unexplored and unwanted environment. Relatively thottada marine 
sediments have never been explored for microbial diversity and 
microbial metabolites. This is the first report on the microbial resource 
of Thottada marine sediments. Due to the different types of soil present 
in this area, geographical variation and uniqueness it is quite likely that 
there is vast distribution of secondary metabolites producing marine 
actinobacteria in this environment. This study was focused on isolation 
of those marine actinobacteria from Thottada sediments samples and to 
evaluate their antimicrobial and antioxidant activity with the eventual 
objective of discovering novel bioactive compounds.
METHODS
Chemicals and media
All chemicals used were of the highest purity and analytical grade. 
Starch Casein Agar (SCA), Actinomycetes Isolation Agar (AIA), 
International Streptomyces agar-2 (ISP-2), ISP-7, ISP-4, Mueller Hilton 
Agar, potato dextrose agar, potato dextrose broth, nutrient broth, 
soluble starch, glucose, yeast extract, CaCo3, FeSO4.7H2O, CuSO4.5H2O, 
ZnSo4.7H2O, MnCl2.4H2O, ferrozine, ascorbic acid and 2,2-diphenyl-1-
picrylhydrazyl (DPPH) were purchased from Hi Media Laboratories, 
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Mumbai, India. Potassium ferricyanide, ferric chloride, trichloroacetic 
acid and solvents were obtained from Sisco Research Laboratories Pvt., 
Ltd., Mumbai, India.
Sample collection
Soil sample was collected from Thottada marine sediment (11.8424° N, 
75.4214° E) Kannur, Kerala. The soil sample was collected at a depth of 
10-20 cm from the top layer and then the samples were transferred into 
sterile bag and transported to the laboratory. The collected samples 
were stored at 4°C for further studies.
Isolation of marine actinobacteria
The actinobacteria were isolated by spread plate technique on starch-
casein agar and AIA after serial dilution in 50% sea water. All agar 
plates were supplemented with 100 μg/ml potassium dichromate and 
nalidixic acid to avoid fungal and bacterial contamination and incubated 
at room temperature form 7 to 30 days. Powdery and leathery colonies 
were isolated, purified and stored at 4°C until further use [12].
Fermentation of isolated actinobacterial culture
In 50 ml of production media (soluble starch: 25 g, glucose: 10 g, yeast 
extract: 2 g, CaCO3: 3 g, 1 ml of trace elements in 1000 ml distilled water), 
all six isolates were separately inoculated in 100 ml conical flask at room 
temperature for 1 week in a shaker (200-150 rpm). After incubation, 
the broths were centrifugation at 10,000 rpm for 10 minutes and the 
supernatant was collected to carry out the activities.
Antimicrobial activity
Antibacterial activity of actinobacterial isolates
Agar well diffusion method was used to determine the antibacterial 
activity of the crude extract. Using a sterile gel borer 6 mm diameter 
of the well was made on agar media. Inoculums of clinical pathogens 
(0.1 ml) were spread on the plates, and 100 µl of crude extract (20 µg/ml 
to 100 µg/ml) was loaded in different wells to evaluate their activity 
against clinical pathogens such as Staphylococcus aureus, Escherichia 
coli, Salmonella typhi, Pseudomonas aeruginosa, and Klebsiella sp. As 
a positive control chloramphenicol was used and dimethyl sulfoxide 
without actinobacterial extract was used as blank. Plates were 
incubated for 24 hrs at 37°C. After 24 hrs of incubation, plates were 
checked for the zone of inhibition [2].
Antifungal activity of actinobacterial isolates
Actinobacterial Isolate DV-35 was inoculated in production media 
and incubated for 5 days at 28°C. After incubation, the cultures were 
centrifuged at 10,000 rpm for 15 minutes and the supernatant was 
collected for extract production. Inoculums of fungal pathogens (0.1 ml) 
were spread on the plates, and 100 µl of crude extract (20 µg/ml to 
100 µg/ml) was loaded in different wells to evaluate the antifungal 
activity against Aspergillus niger and Aspergillus flavus. Plates were 
incubated for 24 hrs at 37°C. After 24 hrs of incubation, plates were 
checked for the zone of inhibition [12].
ANTIOXIDANT ASSAY
DPPH assay
Sample volumes of 1 ml were pipetted out into separate test tubes. 
2 ml of DPPH was added to the test tubes and then mixed. Methanol 
(3 ml) was used as blank. A mixture of 1ml of methanol and 2 ml of 
DPPH acted as the control. All the test tubes were then incubated at 
room temperature for 30 minutes in a dark room. The absorbance was 
then measured at 517 nm using the ultraviolet spectrophotometer [13]. 
The anti-oxidant activity (%) was calculated using the formula:
Antioxidantactivity = (C−T/C)100
Where, C is absorbance of control and T is absorbance of test.
Reducing power assay
A sample volume of 1.0 ml was dissolved in 1.0 ml of phosphate buffer 
and was mixed well with 1.0 ml of 1% potassium Fe [K3Fe(CN)6], and 
then this mixture was incubated at 50°C for 20 minutes. Subsequently, 
1.0 ml of trichloroacetic acid and 1.0 ml milliQ water were added. 
Finally, the solution was mixed with 0.1 ml of 0.1% ferric chloride. 
The mixture was incubated at 50°C for 10 minutes. Absorbance was 
measured at 700 nm [14].
Metal chelating assay
The metal chelating activity of the extract was done by mixing 0.5 ml 
of extract with 1.6 ml milliQ water. Subsequently, FeCl2 (0.05 ml) of 
was added in a test tube. This reaction was initiated by the addition of 
5 mm ferrozine (0.1 ml). The solution was mixed well and allowed to 
stand for 10 minutes at 40°C. After the incubation period, absorbance 
was measured using a spectrophotometer at 562 nm. Distilled water 
was used as a control. Instead of FeCl2 distilled water was used as 
blank [15].
Identification of potential marine actinobacterial strains
Identification of the potential isolates showing good antimicrobial 
and antioxidant activity was done using the key of Nonomura [16] 
and methods of Shirling and Gottlieb [17]. Along with this species 
level identification was also confirmed using cell wall composition 
analysis and by micromorphological studies [18]. Finally, the complete 
identification was done using molecular characterization based 
on 16S rRNA sequencing (Yaazh Xenomics, Chennai, Tamil Nadu, 
India). Bacterial genomic DNA was isolated using the InstaGeneTM 
Matrix Genomic DNA isolation Kit. The fragments were amplified bi-
directionally using the forward (5′-AGAGTTTGATCMTGGCTCAG-3′) and 
reverse (5′- TACGGYTACCTTGTTACGACTT -3′) primers (MJ Research 
Peltier Thermal Cycler). The sequence was analyzed by ABI 3730xl 
capillary DNA sequencer (ABI Prism 310 Genetic Analyzer, Tokyo, 
Japan). Finally, the sequence was observed for similarity using NCBI 
BLAST similarity tool.
Statistical analysis
Using two-way analysis of variance values were analyzed between 
groups of same or different dpi. All values are shown as mean ± standard 
deviation. The significance of the differences between the mean values 




Isolation of marine actinobacteria was done on SCA and AIA. The 
result obtained in the present study reveals that the salt pan sediment 
samples are rich in actinobacterial population. From the collected 
samples, a total of 6 actinobacterial colonies were isolated. Considering 
the total number of isolates, the maximum number were isolated on 
AIA (4), followed by SCA (2). The isolates were identified by using 
culture characteristics as mentioned in ISP manual. All 6 isolates were 
belonging to the genera Streptomyces sp.
Antibacterial activity of actinobacterial extract
The bioactive potential of all 6 isolates was evaluated by testing their 
antibacterial potential against gram positive and negative bacteria. 
Among 6 only one isolate DV-35 showed antimicrobial activity against 
all test pathogens. Cell-free supernatant of DV-35 showed maximum 
inhibition against P. aeruginosa with a zone of inhibition of 18 mm, 
followed by S. typhi (17 mm) and Klebsiella sp. (13 mm). Antibacterial 
profile shown by isolate DV-35 is represented in Table 1. The extract 
showed maximum activity at a dose of 100 µg/ml against all test 
pathogens.
Antifungal activity of actinobacterial extract
Isolate DV-35 showed good antifungal activity against A. niger and 
A. flavus. Cell-free supernatant of DV-35 showed maximum zone of 
inhibition (19 mm) against A. niger at a dose of 100 µg/ml followed 
by 15 mm of inhibition at a dose of 80 µg/ml. Similarly, DV-35 showed 
maximum activity against A. flavus (17 mm) at a dose of 100 µg/ml 
followed by 80 µg/ml with a zone of inhibition of 14 mm (Fig. 1).
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DPPH scavenging assay
DPPH assay is the reduction of purple color of DPPH in the presence 
of hydrogen-donating antioxidant, lead to the development of yellow-
colored non-radical form of DPPH. The DPPH scavenging activity was 
increased with an increase in the cell-free extract. Maximum activity was 
observed at a concentration of 100 µg/ml (Fig. 2a). Isolate DV-35 showed 
80.12% of DPPH scavenging activity with an inhibitory concentration 
(IC50) value of 60 µg/ml. The results indicate that the less dose of marine 
actinobacterial extract exhibited the capability to lessen the DPPH radical, 
which indicated that extract possesses excellent antioxidant activity.
Reducing power assay
Reducing power assay is measured by the electron donating capability 
of an antioxidant. Fe3+ complex gets converted to the ferrous form in 
the presence of reducers, which is a significant indicator of antioxidant 
activity. The positive test was indicated by formation of green color. 
An increase in the absorbance of the reaction mixtures indicates an 
increase in reducing power. Potent isolate DV-35 showed maximum 
reducing power activity (Fig. 2b).
Metal chelating assay
Formation of ferrous and ferrozine complex interfered the antioxidant 
from marine actinobacteria, which suggests that actinobacterial crude 
extract poses metal chelating activity and captures ferrous ion before 
it reacts with ferrozine. Isolate DV-35 showed a good metal chelating 
assay with an IC50 value of 80 µg/ml. At a dose of 100 µg/ml DV-35 
showed maximum metal chelating activity (Fig. 2c).
Identification of potential isolate DV-35
Using 16S rRNA sequencing the potential isolate was identified as 
Streptomyces variabilis. Primary identification of potential strains done 
using the key of Nonomura, micromorphological studies and cell wall 
composition analysis also showed similar results (Table 2). Isolate 
DV-35 formed an extensively branched substrate mycelium which 
carried a rectiflexcible and smooth surface (Figs 3 and 4). Potential 
isolate showed 97% of similarity with S. variabilis in the blast search 
analysis. The 16S rRNA sequencing of potential strains was confirmed 
that it occupies a distinctive phylogenetic position with the radiation, 
including representatives of the family using neighbor joining tree 
(Fig. 5).
DISCUSSION
Marine actinobacterial are known producers or secondary metabolites. 





20 µg/ml 40 µg/ml 60 µg/ml 80 µg/ml 100 µg/ml
1. Staphylococcus aureus 3 mm 5 mm 8 mm 10 mm 12 mm
2. Escherichia coli 1 mm 4 mm 7 mm 9 mm 10 mm
3. Salmonella typhii 2 mm 6 mm 10 mm 14 mm 17 mm
4. Pseudomonas aeruginosa 3 mm 7 mm 11 mm 15 mm 18 mm
5. Klebsiella sp. 4 mm 6 mm 10 mm 11 mm 13 mm
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marine actinobacterial isolation was reported [20]. In our study, all 
actinobacterial colonies were isolated on actinobacterial colonies and 
SCA which is in agreement with the previous reports.
In antimicrobial activity, our extract showed very good activity against 
both bacterial and fungal pathogens. In a study antibacterial activity of 
Streptomyces sp. isolated from Sankarabarani River was reported against 
S. typhi and P. aeruginosa with a zone of inhibition of 17 mm and 22 mm 
respectively [21]. Similarly, in another study marine actinobacteria 
isolated from Rameshwaram showed antimicrobial activity against 
P. aeruginosa with a zone of 16 mm [22]. Our study showed better 
and similar results when compared with all available reports. Hence 
actinobacterial crude extracts isolated from Thottada marine sediments 
can be considered as a potential source for the development of 
antibacterial drugs. In a previous report, antifungal activity of marine 
Actinomycetes isolated from Nicobar marine sediments showed low 
activity against A. niger with a zone of inhibition of 10 mm [12]. Similarly, 
Streptomyces sp. isolated from marine sediments of Sankarabarani 
River showed 17 mm of inhibition against Candida albican [21]. Other 
reports are available on the antifungal activity of actinobacteria isolated 
from different sources like Rathnagiri hills, Where Silambarasan et al., 
2012 reported antifungal activity (17 mm) against A. flavus [23]. 
Actinobacteria isolated from Pulicat Lake, Tamil Nadu showed very less 
activity against A. niger [24]. Our study has shown better results when 
compared with all available reports with a zone of inhibition of 18 mm, 
which makes the finding stronger.
Isolate DV-35 extract also showed a promising hand towards antioxidant 
drug development. The antioxidant activity of marine actinobacteria 
isolated from Nicobar marine sediments was reported previously 
were in DPPH assay extract showed 79% of activity [14]. Similarly, 
85% of DPPH activity was reported from marine actinobacteria 
isolated from Chennai marine sediments [15]. When compared with 
the mentioned results our extract also showed promising data to 
exploit DV-35 actinobacterial crude extract for the development of 
antioxidant drugs. In a previous report, marine actinobacteria isolated 
from Nicobar sediments showed good reducing power assay with an 
absorbance value of 2.1 at 700 nm at a dose of 100 µg/ml [14]. In this 
study, our extract came up with an absorbance value of 1.2 at a dose of 
100 µg/ml which also shows the antioxidant potential of actinobacteria 
crude extract. In a previous report, antioxidant activity of marine 
actinobacterial isolated from salterns showed 85% of metal chelating 
activity [15]. Similarly, in another report, 82% of activity was reported 
from Streptomyces sp. isolated from Chennai marine sediments [25]. 
Our study reported less activity (76%) when compared with previous 
results, but 76% of activity also suggests that actinobacteria isolated 
from Thottada marine sediments can be considered as a source for the 
production of the antioxidant agent.
CONCLUSION
Marine actinomycetes are more miscellaneous and unique with the 
ability to produce different bioactive compounds. The actinomycetes 
isolated in the current study may be a part of the entire diversity present 
in the Thottada marine environment. Here in this study potential isolate 
showed very good antimicrobial activity against clinical pathogens and 




Color of aerial mycelium Off white
Melanoid pigment −
Reverse side pigment +
Soluble pigment −
Acid fast staining −





antimicrobial and antioxidant compound. Here in this study, we have 
isolate marine actinobacterial from a new marine environment which 
was not reported previously anywhere. Mentioned media for isolation 
of marine actinobacterial have been widely used in many studies for 
isolation of marine actinobacterial from different environmental 
sources. Isolation of a large number of colonies on AIA was reported 
previously [19]. Similarly, in another study SCA for increased level of 
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potential of actinobacteria has shown that S. variabilis DV-35 isolated 
from Thottada marine sediments, Kannur, Kerala can be used as a 
promising source for the development of antimicrobial and antioxidant 
drugs.
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